Outcomes of positron emission tomography-staged clinical N3 breast cancer treated with neoadjuvant chemotherapy, surgery, and radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 5, 2011, Pages

  Park, Hae Jin ^b   Shin, Kyung Hwan ^a   Cho, Kwan Ho ^a   Park, In Hae ^a   Lee, Keun Seok ^a   Ro, Jungsil ^a   Jung, So Youn ^a   Lee, Seeyoun ^a   Kim, Seok Won ^a   Kang, Han Sung ^a   Chie, Eui Kyu ^b   Ha, Sung Whan ^b  

^a National Cancer Center   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Breast cancer; N3; Neoadjuvant chemotherapy; PET; Radiotherapy

Indexed keywords

BREAST CANCER; BREAST CONSERVING SURGERY; CURATIVE INTENT; DISEASE-FREE SURVIVAL; DISTANT METASTASIS; LOCOREGIONAL CONTROL; LOCOREGIONAL RECURRENCE; LYMPH NODE; N3; OVERALL SURVIVAL RATES; PET SCAN; POSITRON EMISSION; PRIMARY TREATMENT; REGIONAL FAILURES; TREATMENT FAILURE; TREATMENT OUTCOMES;

BODY FLUIDS; CHEMOTHERAPY; DIAGNOSIS; DISEASES; PATHOLOGY; POLYETHYLENE TEREPHTHALATES; POSITRONS; RADIOTHERAPY; SURGERY;

POSITRON EMISSION TOMOGRAPHY;

ANTHRACYCLINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FOLLOW UP; HUMAN; IRRADIATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELAPSE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC IRRADIATION; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT FAILURE;

EID: 81855184918     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.11.061     Document Type: Article

References (29)

1. A. Chen, F. Meric-Bernstam, and K. Hunt Breast conservation after neoadjuvant chemotherapy Cancer 103 2005 689 695
2. E. Huang, S. Tucker, and E. Strom Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy J Clin Oncol 22 2004 4691 4699
3. R. Brito, V. Valero, and A. Buzdar Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience J Clin Oncol 19 2001 628 633 (Pubitemid 32119077)
4. E. Huang, E. Strom, and V. Valero Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis Int J Radiat Oncol Biol Phys 67 2007 490 496 (Pubitemid 46108307)
5. Y. Zhang, J. Oh, and G. Whitman Clinically apparent internal mammary nodal metastasis in patients with advanced breast cancer: Incidence and local control Int J Radiat Oncol Biol Phys 77 2010 1113 1119
6. F. Puglisi, A. Follador, and A.M. Minisini Baseline staging tests after a new diagnosis of breast cancer: Further evidence of their limited indications Ann Oncol 16 2005 263 266 (Pubitemid 40309307)
7. J. van der Hoeven, N. Krak, and O. Hoekstra 18F-2-fluoro-2-deoxy-D- glucose positron emission tomography in staging of locally advanced breast cancer J Clin Oncol 22 2004 1253 1259 (Pubitemid 41079839)
8. L. Weir, D. Worsley, and V. Bernstein The value of FDG positron emission tomography in the management of patients with breast cancer Breast J 11 2005 204 209 (Pubitemid 40664065)
9. W.B. Eubank, and D.A. Mankoff Evolving role of positron emission tomography in breast cancer imaging Semin Nucl Med 35 2005 84 99 (Pubitemid 40568742)
10. J. Bellon, R. Livingston, and W. Eubank Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) Am J Clin Oncol 27 2004 407 410 (Pubitemid 39045254)
11. W. Eubank, D. Mankoff, and J. Takasugi 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer J Clin Oncol 19 2001 3516 3523 (Pubitemid 32730089)
12. D. Lardinois, W. Weder, and T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507 (Pubitemid 36706537)
13. M.E. Juweid, and B.D. Cheson Role of positron emission tomography in lymphoma J Clin Oncol 23 2005 4577 4580 (Pubitemid 46224057)
14. H. Schoder, J. Meta, and C. Yap Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma J Nucl Med 42 2001 1139 1143 (Pubitemid 32717828)
15. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials Lancet 366 2005 2087 2106 (Pubitemid 41797643)
16. H.M. Nielsen, M. Overgaard, and C. Grau Loco-regional recurrence after mastectomy in high-risk breast cancer - risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials Radiother Oncol 79 2006 147 155 (Pubitemid 43867814)
17. J. Ragaz, I.A. Olivotto, and J.J. Spinelli Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-Year results of the British Columbia randomized trial J Natl Cancer Inst 97 2005 116 126 (Pubitemid 40277091)
18. S.E. Singletary, C. Allred, and P. Ashley Revision of the American Joint Committee on Cancer staging system for breast cancer J Clin Oncol 20 2002 3628 3636 (Pubitemid 34983222)
19. K.S. Lee, J. Ro, and B.H. Nam A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer Breast Cancer Res Treat 109 2008 481 489 (Pubitemid 351692059)
20. K.S. Lee, J. Ro, and E.S. Lee Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: A phase II trial Invest New Drugs 28 2010 83 90
21. E. Harris, and A. Albert Survivorship analysis for clinical studies 1991 Dekker New York
22. E. Huang, E. Strom, and G. Perkins Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score Int J Radiat Oncol Biol Phys 66 2006 352 357 (Pubitemid 44332738)
23. S. McGuire, A. Gonzalez-Angulo, and E. Huang Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy Int J Radiat Oncol Biol Phys 68 2007 1004 1009 (Pubitemid 47048565)
24. A. Chung, D. Liou, and S. Karlan Preoperative FDG-PET for axillary metastases in patients with breast cancer Arch Surg 141 2006 783 788 discussion 788-789 (Pubitemid 44268521)
25. H. Schirrmeister, T. Kuhn, and A. Guhlmann Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: Comparison with the standard staging procedures Eur J Nucl Med 28 2001 351 358
26. U. Veronesi, C. De Cicco, and V.E. Galimberti A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases Ann Oncol 18 2007 473 478 (Pubitemid 46359625)
27. B. Fisher, A. Brown, and E. Mamounas Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 1997 2483 2493 (Pubitemid 27289876)
28. H.M. Kuerer, L.A. Newman, and T.L. Smith Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy J Clin Oncol 17 1999 460 469 (Pubitemid 29075229)
29. S.Y. Jung, S.K. Kim, and B.H. Nam Prognostic Impact of [18F] FDG-PET in operable breast cancer treated with neoadjuvant chemotherapy Ann Surg Oncol 17 2010 247 253